Skip to content
Explore expert articles on technology trends, business stra…

Zimbabwe Rejects ‘One-Sided’ American Health Aid Package Over Information Apprehensions

Health aid illustration
The offered American financial assistance would have supported programmes for treating and preventing HIV/Aids, tuberculosis, and malarial diseases.

Zimbabwe has rejected a significant US health deal worth 367 million US dollars (272 million pounds) over five years due to Washington's demand for confidential information.

This rejection came to light after a internal memorandum dated December was leaked, which showed Head of State Emmerson Mnangagwa deemed the agreement was "unbalanced".

An official representative later stated that the United States was demanding access to biological samples for research and commercial purposes while refused to guarantee the resulting advantages from future medical innovations.

"We are forced to start the difficult and regrettable task of scaling back our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.

Her embassy said the US had furnished over $1.9bn in health funding to Zimbabwe over the last two decades.

A doctors' association in Zimbabwe has appealed for more dialogue to secure a agreement agreeable to both sides so the country's vital HIV treatment initiative can proceed.

Broader Context

This rejection comes after a similar situation in Kenya, where a court halted a similar health funding agreement following concerns were filed about the security of Kenyans' medical information.

Since returning to the presidency last year, US President Donald Trump has drastically cut foreign aid and shut down the US Agency for International Development (USAID).

USAID had administered aid for the American government, but Trump stated its spending was "wasteful" and his government was pursuing direct bilateral agreements to enhance openness and responsibility.

Based on reports, 16 nations in Africa have so far agreed to these new agreements, representing over $18.3bn in committed funds.

Specifics of the Rejected Deal

This assistance for Zimbabwe would have gone towards "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".

"We are confident this collaboration could have provided extraordinary benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children presently receiving HIV treatment via American-funded initiatives," Tremont commented.

However, official spokesman Nick Mangwana argued the arrangement was "asymmetrical".

"Our nation was requested to surrender its genetic material and health information for a long time, with no equivalent assurance of benefiting from any scientific breakthroughs – such as new medicines or tests – that could be developed from that shared data," Mangwana explained.

"In essence, our nation would supply the raw materials for scientific discovery with no certainty that the final treatments would be available to our citizens should a future health crisis emerge."

Sovereignty and Global Health

He also said that the American exit from the World Health Organization (WHO) and its push of bilateral deals were upending frameworks already established through the international organization.

The spokesperson gave as an example its Pathogen Access and Benefit Sharing system designed to deal with potential pandemics.

"This system is designed to ensure that when a nation provides its data, the benefits – including vaccines and treatments – are distributed fairly, not commercialised solely by those with the resources to create them."

The government's concerns over the US deal "should not be misconstrued as opposition to America," he added.

"We are open to ongoing discussions with our US partners on how subsequent co-operation could be structured in a manner that respects the sovereignty and dignity of both nations."

Health Experts Response

Medical experts stated it recognised the government's concerns, but recommended that talks should continue considering a large portion of the nation's Aids initiatives were funded by international support.

"Where specific concerns exist, including those relating to data governance or agreement terms, these can often be resolved through detailed discussion and negotiated safeguards," the group said.

The situation highlights the complex debate between receiving crucial international aid and protecting national sovereignty in an ever more data-driven world.

By

Kara Chase

A tech entrepreneur and writer passionate about sharing insights on digital transformation and startup culture.

Wise Ideas

Type to search articles.